Skip to main content
. 2022 May 31;31(5):137–140. doi: 10.1007/s40629-022-00214-9

Table 1.

Diagnostics of anaphylaxis to drug excipients

Excipient Diagnostics
Skin tests Laboratory tests Challenge tests
Patent blue V

Prick (10−1/pure) [6]

i. d. (10−2) [6]

BATa [7]
Polysorbate 80

Prick (pure)

i. d. (10−2, 10−1) [9]

BATa 200 mgb p.o. [9]

Gelatin

(Galactose-α-[1,3]-galactose)

Prick (10−1, pure) [16]

i. d. (10−3–10−1) [16]

IgEc [14, 16]

BATa [19]

Beef-/porcine meet (α-Gal) [20]
Carboxymethyl cellulose

Prick (10 µg/ml) [24]

i. d. (10−2–10−1) [24]

CASTa [24]

BATa [25]

30 mgb [25]
Benzyl alcohol i. d. (0.009%) [27]
Polyethylene glycol

Prick (10−2, pure) [28, 32]

i. d. (10−3–10−1) [28, 32]

IgEa [8]

BATd [32]

7.1 ge

BAT Basophile Activation Test, CAST Cellular Allergy Stimulation Test, i.d. intradermal, p.o. per os

aNo commercial test

bMaximal dose

cThermo Fisher, Freiburg, Germany

dBühlmann, Basel, Switzerland

eMaximal cumulative dose